Back to the main directory
Press Release
- Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings Inc by GlobeNewsWire
- Man Group PLC : Form 8.3 - LondonMetric Property plc by GlobeNewsWire
- Man Group PLC : Form 8.3 - Serica Energy plc by GlobeNewsWire
- Southside Bancshares, Inc. Announces Financial Results for the First Quarter Ended March 31, 2025 by GlobeNewsWire
- HighPeak Energy, Inc. Announces 2025 First Quarter Earnings Release and Conference Call Dates by GlobeNewsWire
- Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025 by GlobeNewsWire
- U.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB) by GlobeNewsWire
- Serina Therapeutics to Present at JonesResearch Virtual CNS Day by GlobeNewsWire
- Comstock to Host First Quarter 2025 Earnings and Business Update Call by GlobeNewsWire
- Xylo Technologies: Revoltz Secures First Institutional Client for PORTO EV Logistics Deployment by GlobeNewsWire
- Sanoma Oyj:n varsinaisen yhtiökokouksen ja hallituksen päätökset by GlobeNewsWire
- EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting by GlobeNewsWire
- Communiqué de presse : by GlobeNewsWire
- PolyPid to Report First Quarter 2025 Financial Results and Operational Highlights on May 14, 2025 by GlobeNewsWire
- WEBTOON Entertainment Inc. to Report First Quarter 2025 Financial Results on May 13, 2025 by GlobeNewsWire
- H&E Rentals Reports First Quarter 2025 Results by GlobeNewsWire
- Oruka Therapeutics to Present at Bank of America Securities 2025 Health Care Conference by GlobeNewsWire
- Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Patients in Cohort 6 from its Phase 1 Trial of PAS-004 in Advanced Cancer Patients by GlobeNewsWire
- Cullinan Therapeutics to Initiate Study of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Sjögren’s Disease in the United States by GlobeNewsWire
- Seres Therapeutics Presents Data at the 2025 Digestive Disease Week Conference Highlighting the Potential for Live Biotherapeutics to Treat Inflammatory and Immune Diseases by GlobeNewsWire
- Perspective Therapeutics Announces First Patient Dosed with PSV359 in a Phase 1/2a Study in Patients with FAP-α Positive Solid Tumors by GlobeNewsWire
- LGI Homes, Inc. Reports First Quarter 2025 Results by GlobeNewsWire
- First Commonwealth Announces First Quarter 2025 Earnings; Increases Quarterly Dividend by GlobeNewsWire
- Luckin Coffee Announces First Quarter 2025 Financial Results by GlobeNewsWire
- Troilus annonce une intersection record de 2,44 g/t d’équivalent or sur 56 mètres dans la zone Southwest by GlobeNewsWire